These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
473 related items for PubMed ID: 27791390
1. Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models. Choi KE, Song JS, Kang B, Eom Y, Kim HM. Curr Eye Res; 2017 May; 42(5):666-671. PubMed ID: 27791390 [Abstract] [Full Text] [Related]
2. Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface. Hori Y, Kageyama T, Sakamoto A, Shiba T, Nakamura M, Maeno T. J Ocul Pharmacol Ther; 2017 May; 33(6):493-497. PubMed ID: 28346860 [Abstract] [Full Text] [Related]
3. Conjunctival expression of the P2Y2 receptor and the effects of 3% diquafosol ophthalmic solution in dogs. Terakado K, Yogo T, Kohara Y, Soeta S, Nezu Y, Harada Y, Hara Y, Amasaki H, Tagawa M. Vet J; 2014 Oct; 202(1):48-52. PubMed ID: 25178686 [Abstract] [Full Text] [Related]
4. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study. Lee KB, Koh KM, Kwon YA, Song SW, Kim BY, Chung JL. Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695 [Abstract] [Full Text] [Related]
5. Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye. Koh S, Maeda N, Ikeda C, Oie Y, Soma T, Tsujikawa M, Watanabe H, Nishida K. Acta Ophthalmol; 2014 Dec; 92(8):e671-5. PubMed ID: 24863298 [Abstract] [Full Text] [Related]
6. The effects of 3% diquafosol sodium application on the tear functions and ocular surface of the Cu,Zn-superoxide dismutase-1 (Sod1)-knockout mice. Kojima T, Dogru M, Ibrahim OM, Nagata T, Higa K, Shimizu T, Shirasawa T, Satake Y, Shimazaki S, Shimazaki J, Tsubota K. Mol Vis; 2014 Dec; 20():929-38. PubMed ID: 24991185 [Abstract] [Full Text] [Related]
7. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Tauber J, Davitt WF, Bokosky JE, Nichols KK, Yerxa BR, Schaberg AE, LaVange LM, Mills-Wilson MC, Kellerman DJ. Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479 [Abstract] [Full Text] [Related]
8. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery. Baek J, Doh SH, Chung SK. Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809 [Abstract] [Full Text] [Related]
9. Immediate Effects of 3% Diquafosol and 0.1% Hyaluronic Acid Ophthalmic Solution on Tear Break-Up Time in Normal Human Eyes. Nam KT, Ahn SM, Eom Y, Kim HM, Song JS. J Ocul Pharmacol Ther; 2015 Dec; 31(10):631-5. PubMed ID: 26630617 [Abstract] [Full Text] [Related]
10. Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes. Yokoi N, Kato H, Kinoshita S. Am J Ophthalmol; 2014 Jan; 157(1):85-92.e1. PubMed ID: 24200231 [Abstract] [Full Text] [Related]
11. Secreted Mucins on the Ocular Surface. Hori Y. Invest Ophthalmol Vis Sci; 2018 Nov 01; 59(14):DES151-DES156. PubMed ID: 30481820 [Abstract] [Full Text] [Related]
12. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials. Wu D, Chen WQ, Li R, Wang Y. Cornea; 2015 Jun 01; 34(6):644-50. PubMed ID: 25909234 [Abstract] [Full Text] [Related]
13. Effects of Menthol-Containing Artificial Tears on Tear Stimulation and Ocular Surface Integrity in Normal and Dry Eye Rat Models. Ahn S, Eom Y, Kang B, Park J, Lee HK, Kim HM, Song JS. Curr Eye Res; 2018 May 01; 43(5):580-587. PubMed ID: 29419317 [Abstract] [Full Text] [Related]
14. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease. Mun Y, Kwon JW, Oh JY. BMC Ophthalmol; 2018 Sep 05; 18(1):237. PubMed ID: 30185156 [Abstract] [Full Text] [Related]
15. Diquafosol Ophthalmic Solution Increases Pre- and Postlens Tear Film During Contact Lens Wear in Rabbit Eyes. Nagahara Y, Koh S, Oshita Y, Nagano T, Mano H, Nishida K, Watanabe H. Eye Contact Lens; 2017 Nov 05; 43(6):378-382. PubMed ID: 27243352 [Abstract] [Full Text] [Related]
16. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye. Li X, Kang B, Woo IH, Eom Y, Lee HK, Kim HM, Song JS. Invest Ophthalmol Vis Sci; 2018 Jun 01; 59(7):3104-3114. PubMed ID: 30025127 [Abstract] [Full Text] [Related]
17. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model. Moore CP, McHugh JB, Thorne JG, Phillips TE. Invest Ophthalmol Vis Sci; 2001 Mar 01; 42(3):653-9. PubMed ID: 11222523 [Abstract] [Full Text] [Related]
18. Prominent Decrease of Tear Meniscus Height With Contact Lens Wear and Efficacy of Eye Drop Instillation. Nagahara Y, Koh S, Maeda N, Nishida K, Watanabe H. Eye Contact Lens; 2015 Sep 01; 41(5):318-22. PubMed ID: 25839348 [Abstract] [Full Text] [Related]
19. An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca. Gilbard JP, Rossi SR. Ophthalmology; 1992 Apr 01; 99(4):600-4. PubMed ID: 1584579 [Abstract] [Full Text] [Related]
20. Impact of Cigarette Smoking on Tear Function and Correlation between Conjunctival Goblet Cells and Tear MUC5AC Concentration in Office Workers. Uchino Y, Uchino M, Yokoi N, Dogru M, Kawashima M, Komuro A, Sonomura Y, Kato H, Argüeso P, Kinoshita S, Tsubota K. Sci Rep; 2016 Jun 14; 6():27699. PubMed ID: 27297822 [Abstract] [Full Text] [Related] Page: [Next] [New Search]